Intelligent Bio Solutions Inc
(INBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 970 | 1,112 | 710 | 729 | 741 |
| Cost of Goods | 437 | 594 | 508 | 388 | 384 |
| Gross Profit | 533 | 518 | 202 | 341 | 357 |
| Operating Expenses | 3,605 | 4,111 | 3,812 | 3,282 | 3,006 |
| Operating Income | -2,636 | -3,000 | -3,102 | -2,553 | -2,265 |
| Interest Expense | 56 | 4 | 10 | 15 | 14 |
| Other Income | 5 | 9 | 9 | 18 | 21 |
| Pre-tax Income | -2,687 | -2,995 | -3,103 | -2,551 | -2,257 |
| Net Income Continuous | -2,687 | -2,995 | -3,103 | -2,551 | -2,257 |
| Minority Interests | -9 | -12 | -13 | -7 | -7 |
| Net Income | $-2,678 | $-2,983 | $-3,090 | $-2,544 | $-2,250 |
| EPS Basic Total Ops | -2.82 | -3.50 | -3.64 | -4.40 | -4.96 |
| EPS Basic Continuous Ops | -2.83 | -3.50 | -3.64 | -4.42 | -4.98 |
| EPS Diluted Total Ops | -2.82 | -3.50 | -3.64 | -4.40 | -4.96 |
| EPS Diluted Continuous Ops | -2.83 | -3.50 | -3.64 | -4.42 | -4.98 |
| EPS Diluted Before Non-Recurring Items | N/A | -3.50 | -3.70 | -4.40 | -5.00 |
| EBITDA(a) | $-2,308 | $-2,742 | $-2,858 | $-2,438 | $-1,895 |